Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Z Li

Showing results (91-100 of 270) with videos related to

Pageof 27
Sort By:
Pathogens & Immunity|January 16, 2018
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment InterruptionYou Jeong Park, Behzad Etemad, Hayat Ahmed, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
Advanced Materials Technologies|September 13, 2021
SARS-CoV-2 RNA Detection by a Cellphone-Based Amplification-Free System with CRISPR/CAS-Dependent Enzymatic (CASCADE) AssayFilipe S R Silva, Eda Erdogmus, Ahmed Shokr, et al.
The Journal of Infectious Diseases|March 16, 2011
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Zabrina L Brumme, Chanson J Brumme, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 6, 2026
Characterization of HIV humoral immunity during analytical treatment interruptionClara Di Germanio, Brendan G Balasko, Patricia G Villaflor, et al.
Surgical Endoscopy|July 21, 2022
Weight loss outcomes are not compromised in bariatric patients using cannabisEstella Y Huang, Ryan C Broderick, Jonathan Z Li, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
The Journal of Infectious Diseases|September 1, 2021
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 SeverityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
BMC Infectious Diseases|February 11, 2022
Spontaneous intramedullary abscesses caused by Streptococcus anginosus: two case reports and review of the literatureChristian D Cerecedo-Lopez, Joshua D Bernstock, Adam A Dmytriw, et al.
Cell|April 8, 2021
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanismsSarah A Clark, Lars E Clark, Junhua Pan, et al.
Pageof 27

Showing results (91-100 of 270) with videos related to

Sort By:
Pageof 27
Pathogens & Immunity|January 16, 2018
Impact of HLA Class I Alleles on Timing of HIV Rebound After Antiretroviral Treatment InterruptionYou Jeong Park, Behzad Etemad, Hayat Ahmed, et al.
Medrxiv : the Preprint Server for Health Sciences|March 24, 2021
Type I, II, and III interferon signatures correspond to COVID-19 disease severityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
Advanced Materials Technologies|September 13, 2021
SARS-CoV-2 RNA Detection by a Cellphone-Based Amplification-Free System with CRISPR/CAS-Dependent Enzymatic (CASCADE) AssayFilipe S R Silva, Eda Erdogmus, Ahmed Shokr, et al.
The Journal of Infectious Diseases|March 16, 2011
Factors associated with viral rebound in HIV-1-infected individuals enrolled in a therapeutic HIV-1 gag vaccine trialJonathan Z Li, Zabrina L Brumme, Chanson J Brumme, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|March 6, 2026
Characterization of HIV humoral immunity during analytical treatment interruptionClara Di Germanio, Brendan G Balasko, Patricia G Villaflor, et al.
Surgical Endoscopy|July 21, 2022
Weight loss outcomes are not compromised in bariatric patients using cannabisEstella Y Huang, Ryan C Broderick, Jonathan Z Li, et al.
Mbio|March 10, 2021
Viral Rebound Kinetics Correlate with Distinct HIV Antibody FeaturesYannic C Bartsch, Carolin Loos, Evan Rossignol, et al.
The Journal of Infectious Diseases|September 1, 2021
Type I, II, and III Interferon Signatures Correspond to Coronavirus Disease 2019 SeverityMyung-Ho Kim, Shadi Salloum, Jeffrey Y Wang, et al.
BMC Infectious Diseases|February 11, 2022
Spontaneous intramedullary abscesses caused by Streptococcus anginosus: two case reports and review of the literatureChristian D Cerecedo-Lopez, Joshua D Bernstock, Adam A Dmytriw, et al.
Cell|April 8, 2021
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanismsSarah A Clark, Lars E Clark, Junhua Pan, et al.
Pageof 27